| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 2,702 | $104.64 | $282,737.28 | -6.1% | +10.5% | -68.9% | |
| Jun 2, 2021 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 2,899 | $21.57 | $62,531.43 | -1.5% | -2.0% | -82.3% | |
| Jun 2, 2021 | CDNA Caredx, Inc. | Snyderman Ralph78 | Director | Sell | 9,500 | $80.19 | $761,848.87 | -4.2% | -8.4% | -66.9% | |
| Jun 1, 2021 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,577 | $332.23 | $3,181,749.31 | -0.4% | +33.6% | -31.0% | |
| Jun 1, 2021 | PRPO Precipio, Inc. | Danieli Ilan | Chief Executive Officer | Buy | 755 | $3.37 | $2,545.33 | +3.5% | -7.3% | -65.5% | |
| Jun 1, 2021 | PRPO Precipio, Inc. | Sabet Ahmed Zaki47 | Chief Operating Officer | Buy | 151 | $3.37 | $508.72 | +3.2% | -7.3% | -65.5% | |
| Jun 1, 2021 | FLGT Fulgent Genetics, Inc. | Bolger John C65 | Director | Sell | 1,876 | $71.41 | $133,965.54 | -46.9% | +31.9% | -22.4% | |
| Jun 1, 2021 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 12,384 | $111.00 | $1,374,624.00 | -1.6% | -4.4% | -55.3% | |
| Jun 1, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,438 | $59.33 | $144,652.82 | -0.2% | +24.7% | -64.7% | |
| May 28, 2021 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | Chief Operating Officer | Sell | 647 | $73.46 | $47,527.07 | -0.2% | +29.2% | -21.7% | |
| May 28, 2021 | MYGN Myriad Genetics Inc | Spiegelman Daniel K59 | Director | Sell | 7,142 | $28.99 | $207,023.01 | -34.7% | +17.1% | -19.3% | |
| May 28, 2021 | TWST Twist Bioscience Corp | Thorburn James M84 | Chief Financial Officer | Sell | 6,000 | $110.00 | $660,000.00 | -11.4% | +0.4% | -66.5% | |
| May 28, 2021 | A Agilent Technologies, Inc. | McDonnell Padraig71 | Sr. Vice President | Sell | 1,000 | $138.42 | $138,420.00 | -5.6% | +25.8% | -5.0% | |
| May 28, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 13,531 | $60.14 | $813,817.56 | -0.6% | +21.0% | -62.2% | |
| May 28, 2021 | NOTV Inotiv, Inc. | Sagartz John E60 | Chief Strategy Officer | Buy | 2,017 | $24.78 | $49,977.36 | +0.2% | +2.3% | -33.8% | |
| May 27, 2021 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 13,465 | $136.15 | $1,833,351.05 | -25.4% | +26.2% | -4.6% | |
| May 27, 2021 | DHR Danaher Corp /de/ | List Teri55 | Director | Sell | 4,548 | $255.10 | $1,160,194.80 | -21.8% | +25.3% | +4.7% | |
| May 27, 2021 | RDNT Radnet, Inc. | Murdock Michael N45 | EVP &Chief Development Offcr | Sell | 18,333 | $26.88 | $492,855.21 | -21.8% | +14.0% | -21.8% | |
| May 27, 2021 | MTD Mettler Toledo International Inc/ | Spoerry Robert F70 | Director | Sell | 1,000 | $1,300.00 | $1,300,000.00 | -13.7% | +20.3% | +2.3% | |
| May 27, 2021 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs | Sell | 5,985 | $1,300.00 | $7,780,500.00 | -86.2% | +20.3% | +2.3% | |
| May 27, 2021 | PRPO Precipio, Inc. | Cohen David Seth | Director | Sell | 40,178 | $3.99 | $160,310.22 | -4.7% | -3.1% | -67.3% | |
| May 26, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 12,632 | $60.15 | $759,814.63 | -0.6% | +24.0% | -64.5% | |
| May 26, 2021 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 28,358 | $72.91 | $2,067,598.37 | -8.5% | +24.2% | -25.8% | |
| May 25, 2021 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 400,000 | $3.64 | $1,455,972.35 | - | +6.0% | -17.0% | |
| May 25, 2021 | NEO Neogenomics Inc | Shovlin Robert J. | President, Clinical Services | Sell | 130,604 | $39.31 | $5,134,043.24 | -46.5% | +13.9% | -79.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.